TNBIOTCGrain Mill ProductsFiscal year ends December 31
Tanke Biosciences Corp
Financials through Q3 FY2013, quarter ended Sep 30, 2013Last filing: 10-Q on Nov 14, 2013
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $399.72K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2011 Ended Jun 30, 2011 | Aug 15, 2011 | During market hours | – | – | – |
Press releases
Announcements Tanke Biosciences filed with the SEC
CURRENT REPORT
Event dated Dec 19, 2013, from SEC EDGAR
CURRENT REPORT
Event dated Sep 30, 2013, from SEC EDGAR
CURRENT REPORT
Event dated Sep 30, 2013, from SEC EDGAR
CURRENT REPORT
Event dated Aug 23, 2013, from SEC EDGAR
CURRENT REPORT
Event dated Feb 9, 2013, from SEC EDGAR
FORM 8-K
Event dated Dec 20, 2012, from SEC EDGAR
Current report on Form 8-K
Event dated Jan 20, 2012, from SEC EDGAR
Current report on Form 8-K
Event dated Oct 13, 2011, from SEC EDGAR
FORM 8-K
Event dated Aug 5, 2011, from SEC EDGAR
Current report on Form 8-K
Event dated Jul 26, 2011, from SEC EDGAR
Current report on Form 8-K
Event dated May 17, 2011, from SEC EDGAR
Current report on Form 8-K
Event dated Feb 9, 2011, from SEC EDGAR
GREYHOUND - 8K SHARE AGREE
Event dated Jan 6, 2011, from SEC EDGAR
GREYHOUND 8K - AUDITOR
Event dated Apr 22, 2010, from SEC EDGAR
GREYHOUND 8K - AUDITORS
Event dated Oct 14, 2009, from SEC EDGAR